(Total Views: 395)
Posted On: 07/28/2021 3:48:54 PM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Todos Medical Retains CRO for COVID-19 Outpatient and Inpatient Phase 2/3 Clinical Trials for Oral Antiviral 3CL Protease Inhibitor Tollovir
https://newsfilter.io/articles/todos-medical-...b0b344a1dd
https://newsfilter.io/articles/todos-medical-...b0b344a1dd
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)